Logo image of CS

Credit Suisse Group (CS) Stock Fundamental Analysis

NYSE:CS - New York Stock Exchange, Inc. - US2254011081 - ADR - Currency: USD

0.8858  +0.01 (+0.99%)

After market: 0.899 +0.01 (+1.49%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CS. CS was compared to 237 industry peers in the Capital Markets industry. CS has a bad profitability rating. Also its financial health evaluation is rather negative. CS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CS has reported negative net income.
The reported net income has been mixed in the past 5 years: CS reported negative net income in multiple years.
In multiple years CS reported negative operating cash flow during the last 5 years.
CS Yearly Net Income VS EBIT VS OCF VS FCFCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10B -10B 20B 30B

1.2 Ratios

CS has a Return On Assets (1.00%) which is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of 10.01%, CS is in the better half of the industry, outperforming 69.31% of the companies in the same industry.
Industry RankSector Rank
ROA 1%
ROE 10.01%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CS Yearly ROA, ROE, ROICCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 5 -5 -10 -15

1.3 Margins

Looking at the Profit Margin, with a value of 18.68%, CS is in the better half of the industry, outperforming 64.85% of the companies in the same industry.
The Operating Margin and Gross Margin are not available for CS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 18.68%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CS Yearly Profit, Operating, Gross MarginsCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -20 -40

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, CS has more shares outstanding
The debt/assets ratio for CS is higher compared to a year ago.
CS Yearly Shares OutstandingCS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B
CS Yearly Total Debt VS Total AssetsCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200B 400B 600B 800B

2.2 Solvency

A Debt/Equity ratio of 2.80 is on the high side and indicates that CS has dependencies on debt financing.
With a Debt to Equity ratio value of 2.80, CS is not doing good in the industry: 84.65% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.8
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
CS Yearly LT Debt VS Equity VS FCFCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50B 100B 150B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
CS Yearly Current Assets VS Current LiabilitesCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50B 100B 150B

More info and screens

3

3. Growth

3.1 Past

CS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -702.95%.
Looking at the last year, CS shows a very strong growth in Revenue. The Revenue has grown by 48.34%.
Measured over the past years, CS shows a decrease in Revenue. The Revenue has been decreasing by -6.52% on average per year.
EPS 1Y (TTM)-702.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-576.1%
Revenue 1Y (TTM)48.34%
Revenue growth 3Y-12.77%
Revenue growth 5Y-6.52%
Sales Q2Q%318.56%

3.2 Future

CS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.46% yearly.
The Revenue is expected to grow by 2.57% on average over the next years.
EPS Next Y82.2%
EPS Next 2Y39.87%
EPS Next 3Y27.69%
EPS Next 5Y16.46%
Revenue Next Year-4.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y0.61%
Revenue Next 5Y2.57%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CS Yearly Revenue VS EstimatesCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B 25B
CS Yearly EPS VS EstimatesCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CS Price Earnings VS Forward Price EarningsCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CS Per share dataCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CS's earnings are expected to grow with 27.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.87%
EPS Next 3Y27.69%

More info and screens

0

5. Dividend

5.1 Amount

CS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Credit Suisse Group

NYSE:CS (6/9/2023, 8:04:01 PM)

After market: 0.899 +0.01 (+1.49%)

0.8858

+0.01 (+0.99%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)04-24 2023-04-24/dmh
Earnings (Next)07-27 2023-07-27/bmo
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.50B
Analysts46.09
Price Target1.51 (70.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-126.63%
Min EPS beat(2)-230.24%
Max EPS beat(2)-23.02%
EPS beat(4)0
Avg EPS beat(4)-3226.79%
Min EPS beat(4)-11871.5%
Max EPS beat(4)-23.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)174.77%
Min Revenue beat(2)-4.76%
Max Revenue beat(2)354.29%
Revenue beat(4)1
Avg Revenue beat(4)84.46%
Min Revenue beat(4)-9.84%
Max Revenue beat(4)354.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.18%
PT rev (3m)-56.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-45.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.06
P/tB 0.06
EV/EBITDA N/A
EPS(TTM)-3.58
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.24
BVpS15.38
TBVpS14.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1%
ROE 10.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 18.68%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 2.8
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)72.35%
Cap/Depr(5y)87.09%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-702.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-576.1%
EPS Next Y82.2%
EPS Next 2Y39.87%
EPS Next 3Y27.69%
EPS Next 5Y16.46%
Revenue 1Y (TTM)48.34%
Revenue growth 3Y-12.77%
Revenue growth 5Y-6.52%
Sales Q2Q%318.56%
Revenue Next Year-4.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y0.61%
Revenue Next 5Y2.57%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-8.83%
EBIT Next 3Y24.95%
EBIT Next 5YN/A
FCF growth 1Y-65.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.59%
OCF growth 3YN/A
OCF growth 5YN/A